Pediatrix Medical
209 hedge funds and large institutions have $1.2B invested in Pediatrix Medical in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 78 reducing their positions, and 27 closing their positions.
41% more call options, than puts
Call options by funds: $557K | Put options by funds: $395K
1.68% more ownership
Funds ownership: 99.88% → 101.56% (+1.7%)
0% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 27
1% less funds holding
Funds holding: 211 → 209 (-2)
1% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 78
14% less capital invested
Capital invested by funds: $1.39B → $1.2B (-$190M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$15.8M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$6.64M |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$2.58M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.51M |
| 5 |
Goldman Sachs
New York
|
+$2.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
-$9.19M |
| 2 |
SV
Starboard Value
New York
|
-$7.2M |
| 3 |
EARNEST Partners
Atlanta,
Georgia
|
-$3.49M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.4M |
| 5 |
PC
Pavadi Capital
New York
|
-$2.76M |
MD Hedge Fund Activity: Q4 2022 in Review
209 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2022, worth a combined $1.2B — down 14% from $1.39B a quarter earlier.
Fund positioning in MD was balanced in Q4 2022: 27 funds opened new positions, 27 closed out, 77 added to existing stakes and 78 trimmed.
The largest buyer was Lazard Asset Management, adding an estimated $15.8M. The largest seller was River Road Asset Management, cutting an estimated $9.19M.
- 209 institutional investors held Pediatrix Medical (MD) as of Q4 2022, down from 211 in Q3 2022.
- Funds reported $1.2B of Pediatrix Medical stock for Q4 2022, down 14% quarter-over-quarter.
- 27 funds opened new Pediatrix Medical positions in Q4 2022 and 27 closed out, a net change of 0 holders.
- The largest Pediatrix Medical buyer in Q4 2022 was Lazard Asset Management, an estimated $15.8M added.
- The largest Pediatrix Medical seller in Q4 2022 was River Road Asset Management, an estimated $9.19M sold.
Based on aggregated 13F filings for Q4 2022.